UroGen Pharma Ltd. (URGN)
21.04
-0.03
(-0.14%)
USD |
NASDAQ |
Feb 23, 10:53
UroGen Pharma EPS Diluted (Quarterly) : -0.6939 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.4206 |
| Agenus, Inc. | 1.944 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
| Savara, Inc. | -0.1366 |
| Arrowhead Pharmaceuticals, Inc. | 0.219 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -33.35M |
| Revenue (Quarterly) | 27.48M |
| Total Expenses (Quarterly) | 60.83M |
| Enterprise Value | 987.82M |
| Gross Profit Margin (Quarterly) | 88.07% |
| Profit Margin (Quarterly) | -121.3% |
| Earnings Yield | -16.45% |
| Normalized Earnings Yield | -16.45 |